Detalles de la búsqueda
1.
Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1.
J Steroid Biochem Mol Biol
; 192: 105115, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438723
2.
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity.
Mol Cancer Ther
; 18(1): 28-38, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30301864
3.
Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies.
Sci Rep
; 5: 12007, 2015 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26137992
Resultados
1 -
3
de 3
1
Próxima >
>>